Novo Nordisk ranked second in the 2014 Science Careers Top Employers Survey, which is a big jump up the list from last year's ranking where Novo Nordisk came in at number 11. The key drivers of the ranking were the categories 'Treats employees with respect', 'Has loyal employees' and 'Is socially responsible'.
"We're really proud of being ranked number two this year on the prestigious list of the world's best science employers," said Mads Krogsgaard Thomsen, chief science officer and executive vice president at Novo Nordisk. "Our researchers around the world are doing a tremendous job of discussing and developing truly innovative and patient-focused products. The fact that the research community feels that Novo Nordisk is one of the very best places to work matters a great deal for a company growing at Novo Nordisk's pace."
Today Novo Nordisk employs more than 40,000 people globally - a number the company anticipates will rise to more than 60,000 over the next decade. Novo Nordisk Research and Development is a global organisation with more than 6,000 employees working at sites in Denmark, China, US and India.
Novo Nordisk has more than 90 years of experience as a science-driven company with a strong commitment to patients.
"We combine scientific, pharmaceutical and clinical expertise with high ethical standards to continue to improve the quality of life of people living with chronic diseases. As the global leader in diabetes care, millions of people worldwide rely on us to deliver treatments for their disease every day. Additionally, we continue to invest in developing innovative treatments for obesity, haemophilia and growth disorders," says Mads Krogsgaard Thomsen.
The 2014 Science Careers Top Employers Survey is based on 5,394 responses from readers of Science and from employees in the biotechnology and pharmaceutical industry, who were asked to rank the 20 best employers on a number of characteristics.
About Novo Nordisk
Headquartered in Denmark, Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Novo Nordisk employs approximately 40,700 employees in 75 countries, and markets its products in more than 180 countries.